Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
Clinical trial NCT02262858 · COMPLETED
Trial details
- NCT number
- NCT02262858
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2005-10-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.